Skip to content

A Novel diagnostic method using CDO1 gene methylation-Establishment of peritoneal lavage DNA cytology for gastric cancer

A Novel diagnostic method using CDO1 gene methylation-Establishment of peritoneal lavage DNA cytology for gastric cancer - A prospective case series study on peritoneal lavage DNA-cytology for gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026191
Enrollment
400
Registered
2017-02-17
Start date
2016-10-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Sponsors

Department of Surgery, Kitasato University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Histologically proven gastric cancer 2) With written informed consent before surgery 3) Preoperatively diagnosed as cStage I-IV

Exclusion criteria

Exclusion criteria: Patients without preoperative informed consent

Design outcomes

Primary

MeasureTime frame
Concordance rate between conventional CY and DNA-CY

Secondary

MeasureTime frame
Peritoneal relapse-free survival rate between conventional CY and DNA-CY DNA CY1 rate in early gastric cancer

Countries

Japan

Contacts

Public ContactHiroki Harada

Kitasato University School of Medicine Department of Surgery

dm16025@st.kitasato-u.ac.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026